1.Impact of glibenclamide versus Insulin on neurological and functional outcomes of hemorrhagic stroke in diabetic patients
Keyvan Ghasami ; Mohammad Reza Rezvanfar ; Fardin Faraji ; Abolfazl Mohammadbeigi ; Mohammad Rafiee
Neurology Asia 2013;18(2):137-141
Background & Objective: Stroke is one of the common leading causes of morbidity and mortality
worldwide. Diabetes is one of the modifi able risk factors of stroke which is related to a higher mortality
and a poorer outcome. We aimed to evaluate the protective effect of Insulin versus glibenclamide on
the improvement of neurological and functional outcomes of hemorrhagic stroke. Methods: The present
single blind clinical trial was conducted on 100 patients with stroke and diabetes who had referred to
Neurology Emergency Department of Vali-e-Asr hospital, Arak, Iran. The patients were categorized
into two groups according to the glucose control treatment before stroke. Without any randomization,
glibenclamide was used in 45 patients, while others (55 ones) received insulin. National Institute of
Health Stroke Scale (NIHSS) and modifi ed Rankin scale (MRS) systems were used for evaluating
the neurological and functional outcomes. Results: Hemiparesis was the most common sign of the
patients. The mean of changes in NIHSS and MRS scores of the two groups were -29.69±21.4 and
-17.24±21, respectively. Although Insulin group had a higher decrease in NIHSS and MRS scores, no
signifi cant difference was found between the two groups. Both treatment methods had a signifi cant
decreasing effect on NIHSS and MRS scores (p<0.001).
Conclusion: Patients treated with both glibenclamide and insulin had similar decrease in their one
week NIHSS and MRS scores with no signifi cant difference in the two treatment groups.
2.Impact of Metabolic Syndrome on Response to Medical Treatment of Benign Prostatic Hyperplasia.
Ali CYRUS ; Ali KABIR ; Davood GOODARZI ; Afsaneh TALAEI ; Ali MORADI ; Mohammad RAFIEE ; Mehrdad MOGHIMI ; Elham SHAHBAZI ; Elaheh FARMANI
Korean Journal of Urology 2014;55(12):814-820
PURPOSE: To investigate the effect of metabolic syndrome (MetS) on the response to medical therapy of benign prostatic hyperplasia (BPH) after a 3-month period of treatment. MATERIALS AND METHODS: This was a cohort study of 100 patients, 47 with MetS and 53 without MetS, referred to either the primary care unit or referral hospital with BPH who had moderate lower urinary tract symptoms of prostate involvement and were candidates for medical treatment. Our main outcome was response to medical treatment with prazosin 1 mg twice a day and finasteride 5 mg daily in patients with BPH on the basis of International Prostate Symptom Score (IPSS). Multivariate analysis of covariance was used to compare BPH treatment response in patients with and without MetS before and after receiving treatment. RESULTS: The mean volume of the prostate was significantly higher in MetS patients than in patients without MetS (57+/-32.65 mL compared with 46.00+/-20.19 mL, p=0.036). The control group demonstrated an 11-unit reduction in IPSS, whereas those with MetS showed a reduction in the symptom score of only 6 units (p<0.001). Regarding the components of MetS separately, triglyceride (p<0.001), fasting blood sugar (p=0.001), and waist circumference (p=0.028) significantly affected the clinical progression of BPH. The observational nature of this study may be a limitation in comparison with an interventional study. CONCLUSIONS: The results of the present study showed that MetS can negatively affect the response to medical treatment of BPH. Therefore, it is necessary to consider MetS in selecting patients with BPH for drug therapy.
Aged
;
Case-Control Studies
;
Finasteride/*therapeutic use
;
Humans
;
Lower Urinary Tract Symptoms/etiology
;
Male
;
Metabolic Syndrome X/*complications
;
Middle Aged
;
Patient Selection
;
Prazosin/*therapeutic use
;
Prostatic Hyperplasia/complications/*drug therapy/pathology
;
Treatment Outcome
;
Urological Agents/*therapeutic use
3.Autolysin (lytA) recombinant protein: a potential target for developing vaccines against pneumococcal infections
Davoud AFSHAR ; Farzaneh RAFIEE ; Mozhgan KHEIRANDISH ; Solmaz Ohadian MOGHADAM ; Mohammad AZARSA
Clinical and Experimental Vaccine Research 2020;9(2):76-80
Purpose:
N-acetylmuramoyl-l-alanine amidase known as lytA, is an immunogenic protein that plays an important role in the pathogenesis of Streptococcus pneumoniae. It is highly conserved among S. pneumoniae strains and is absent among other Streptococcus species. In the present study, the level of antibodies against the lytA recombinant protein was evaluated in healthy individuals’ sera.
Materials and Methods:
DNA was extracted from S. pneumoniae ATCC 49619 to amplify lytA gene by polymerase chain reaction assay. The lytA amplicon and pET28a vector were separately double digested using Nde-1 and Xho1 restriction enzymes and then ligated together with ligase enzyme. The recombinant plasmid was expressed in Escherichia coli BL21 strain and the lytA recombinant protein purified using nickel-nitrilotriacetic acid affinity chromatography. Western blot was carried to detect lytA recombinant protein. Sixty healthy individual’s sera (at three age groups: group 1, <2; group 2, 2–40; and group 3, 60–90 years old) were collected and the titers of anti-lytA antibodies were determined.
Results:
The lytA gene was highly expressed in E. coli BL21 host. The recombinant lytA protein was purified and confirmed by western blotting. Tukey test analysis showed that there were no significant differences among the age groups considering the anti-lytA titer of 10. However, at the anti-lytA titer of 60, significant differences were observed between group 1 vs. group 2 (p<0.001); group 1 vs. group 3 (p=0.003), and group 2 vs. group 3 (p=0.024).
Conclusion
The lytA protein seems to be a highly immunogenic antigen and a potential target for developing vaccines against pneumococcal infections.
4.Autolysin (lytA) recombinant protein: a potential target for developing vaccines against pneumococcal infections
Davoud AFSHAR ; Farzaneh RAFIEE ; Mozhgan KHEIRANDISH ; Solmaz Ohadian MOGHADAM ; Mohammad AZARSA
Clinical and Experimental Vaccine Research 2020;9(2):76-80
Purpose:
N-acetylmuramoyl-l-alanine amidase known as lytA, is an immunogenic protein that plays an important role in the pathogenesis of Streptococcus pneumoniae. It is highly conserved among S. pneumoniae strains and is absent among other Streptococcus species. In the present study, the level of antibodies against the lytA recombinant protein was evaluated in healthy individuals’ sera.
Materials and Methods:
DNA was extracted from S. pneumoniae ATCC 49619 to amplify lytA gene by polymerase chain reaction assay. The lytA amplicon and pET28a vector were separately double digested using Nde-1 and Xho1 restriction enzymes and then ligated together with ligase enzyme. The recombinant plasmid was expressed in Escherichia coli BL21 strain and the lytA recombinant protein purified using nickel-nitrilotriacetic acid affinity chromatography. Western blot was carried to detect lytA recombinant protein. Sixty healthy individual’s sera (at three age groups: group 1, <2; group 2, 2–40; and group 3, 60–90 years old) were collected and the titers of anti-lytA antibodies were determined.
Results:
The lytA gene was highly expressed in E. coli BL21 host. The recombinant lytA protein was purified and confirmed by western blotting. Tukey test analysis showed that there were no significant differences among the age groups considering the anti-lytA titer of 10. However, at the anti-lytA titer of 60, significant differences were observed between group 1 vs. group 2 (p<0.001); group 1 vs. group 3 (p=0.003), and group 2 vs. group 3 (p=0.024).
Conclusion
The lytA protein seems to be a highly immunogenic antigen and a potential target for developing vaccines against pneumococcal infections.
5. Efficacy evaluation and kinetic study of biosorption of nickel and zinc by bacteria isolated from stressed conditions in a bubble column
Mohammad ARJOMANDZADEGAN ; Mostafa Keshavarz MORAVEJI ; Poorya RAFIEE ; Maryam TAYEBOON
Asian Pacific Journal of Tropical Medicine 2014;7(S1):S194-S198
Objective: To investigate the biosorption potential of isolated bacteria as an alternative biosorbent material for the removal of zinc and nickel from aqueous solution in a bubble column bioreactor. Methords: In this study from four points of waste water treatment plant, some Gram-positive and Gram-negative bacteria under heavy metal stress conditions were isolated by microbiological methods. Biosorption experiments were conducted in a bubble column containing waste water in high concentrations of nickel and zinc inoculated by isolated bacteria. A kinetic study was done to investigate the fitting of either pseudo first-order or second order equations. Results: The 96% removal of zinc and 54% removal of nickel were achieved by biosorption column experiment by the isolated bacteria. A comparison between a non-aerated and aerated column shows a higher removal percentage with the same contact time. The study of contact time in the experiments also confirmed that with more contact time, while the removal efficiency increases the capacity of microorganisms to absorb the metal ions decreases. Results of kinetic study showed pseudo-second-order equation with a coefficient of determination of 0.9648 and 0.9992 for zinc and nickel, and the pseudo-first-order equation with 0.2410 and 0.4794, respectively. Conclusions: It was be concluded that biosorbtion method is a suitable alternative method to remove metal ions for further study in large scale.